Active Surveillance

Active surveillance is a regular monitoring of the state of a patient's existing prostate cancer. The approach is to wait until either tumour expansion or the tumour aggressiveness becomes relevant and limiting for the patient.

If the patient is lucky, an existing prostate cancer (prostate carcinoma) may never need to be treated.

Eine active surveillance eignet sich typischerweise für eine Aggressionsstufe bis und mit Gleason Score 3+3=6 sowie einem PSA unter 10ng/ml

Active surveillance is typically suitable for an aggression level up to and including a Gleason Score of 3+3=6 and a PSA level below 10ng/ml.

Of course, such a treatment strategy must be individually adapted to each patient's state of health and expectations of chances and risks.